O’Brien, Sheila F. http://orcid.org/0000-0002-5332-2789
Asamoah-Boaheng, Michael http://orcid.org/0000-0002-9632-6878
Grunau, Brian http://orcid.org/0000-0003-4103-1383
Krajden, Mel http://orcid.org/0000-0002-3477-8748
Buckeridge, David L. http://orcid.org/0000-0003-1817-5047
Goldfarb, David M. http://orcid.org/0000-0003-0835-9504
Anderson, Maureen
Germain, Marc http://orcid.org/0000-0002-8466-0916
Brown, Patrick http://orcid.org/0000-0003-2541-3744
Stein, Derek R.
Kandola, Kami
Tipples, Graham
Awadalla, Philip http://orcid.org/0000-0001-9946-6393
Lang, Amanda http://orcid.org/0000-0001-6051-8344
Behl, Lesley
Fitzpatrick, Tiffany http://orcid.org/0000-0003-2767-6476
Drews, Steven J. http://orcid.org/0000-0003-2519-1109
Article History
Received: 4 December 2023
Accepted: 24 May 2024
First Online: 9 July 2024
Declarations
:
: N/A.
: N/A.
: N/A.
: Drews has received laboratory supplies from Abbott Pharmaceuticals and consulting fees from Roche.